GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » 3-Year EPS without NRI Growth Rate

ReNeuron Group (ReNeuron Group) 3-Year EPS without NRI Growth Rate

: 36.00% (As of Sep. 2023)
View and export this data going back to 2006. Start your Free Trial

ReNeuron Group's EPS without NRI for the six months ended in Sep. 2023 was $-0.06.

During the past 3 years, the average EPS without NRI Growth Rate was 36.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 29.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 30.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of ReNeuron Group was 82.90% per year. The lowest was -267.60% per year. And the median was 18.65% per year.


Competitive Comparison

For the Biotechnology subindustry, ReNeuron Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group 3-Year EPS without NRI Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, ReNeuron Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's 3-Year EPS without NRI Growth Rate falls into.



ReNeuron Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


ReNeuron Group  (OTCPK:RNUGF) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


ReNeuron Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (ReNeuron Group) Business Description

Industry
Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group (ReNeuron Group) Headlines

From GuruFocus

ReNeuron Announces CTX Cell Line Shows Further Potential

By PRNewswire PRNewswire 05-07-2020

Edison Issues Update on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 07-06-2020

Edison Issues Outlook on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 08-26-2020

Edison Issues Update on ReNeuron Group (RENE)

By ACCESSWIRE AccessWire 04-12-2019

ReNeuron Provides Business Update and Results Notification

By PRNewswire PRNewswire 05-08-2019

ReNeuron Signs New Exosome Research Collaboration

By PRNewswire PRNewswire 06-25-2020